Chinese Herbal Medicines (CHM) (CN12-1410/R), launched in October 2009, is the first English-language academic journal in China dedicated to Chinese materia medica. Jointly sponsored by the Tianjin Institute of Pharmaceutical Research and the Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, CHM provides an international platform for publishing high-quality research on Chinese herbal medicines, traditional medicines, and natural products.

CHM is indexed in ESCI, Scopus, DOAJ, PubMed Central (PMC), EMBASE, CAS, CAB Abstracts, CABI, ProQuest, Elsevier, Toho Shoten, and other major global databases. In the 2024 Journal Citation Reports (JCR), CHM received an Impact Factor (IF) of 8.9 (IF 3.8 in 2023, IF 4.7 in 2024), ranking in Q1 in Chemistry, Medicinal category (3/72). In 2025, it was ranked as a Tier 2 journal for Medicine (major category) and Tier 2 for Medicinal Chemistry (minor category) in the Chinese Academy of Sciences (CAS) journal ranking system. The full text of the journal is also available for search and citation on ScienceDirect.

The editorial committee is composed of 93 experts, of which 13 are academician of Chinese Academy of Engineering and 59 are international members (including 5 from China’s Hong Kong, Macau, and Taiwan). The honorary editors-in-chief are Academician Peigen Xiao, the founder of pharmacophylogenetics and Yungchi Cheng, the Henry Bronson Professor of Pharmacology; The editor-in-chief is Academician Luqi Huang; Associate editors-in-chief are Prof. Rudolf Bauer, Prof. Guido F. Pauli, Prof. Thomas Efferth, Prof. Pulok Kumar Mukherjee, Prof. Shilin Chen, Prof. Dean Guo, and Prof. Xiaobo Sun.

CHM's purpose is to provide a forum for the studies on Chinese herbal medicines, traditional medicines, and natural products. The journal will accept the following contributions: original articles, review, editorial, perspective, focus, letters, short communications, etc. The journal includes the studies on active ingredients and complex formulations of herb medicines in medicinal resource, phytochemistry, pharmacology, toxicology, pharmacokinetics, and therapeutic function by experimental and clinical trials.

CHM is committed to enhancing the global visibility and academic influence of Chinese herbal medicines through rigorous peer review and open academic exchange.